Redwire Corporation has been awarded a NASA single award, indefinite-delivery/indefinite-quantity (IDIQ) contract with a ceiling of $25 million over a five-year period. This contract enables Redwire to fulfill future task orders for biotechnology facilities, on-orbit operations support, mission integration, and related services aboard the International Space Station (ISS). Recently, a $2.5 million task order was issued to Redwire under NASA's In Space Production Applications (InSPA) program to aid in drug development investigations using Redwire's PIL-BOX technology. As a global leader in microgravity research and development technologies, Redwire is set to manage and facilitate experiments and support on-orbit operations for NASA-funded research. The company's biotechnology facilities play a crucial role in NASA's ISS research strategy, expanding on-orbit capabilities in fields such as drug development, cancer research, and tissue engineering.